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SUMMARY
Cyathostomins are ubiquitous nematodes of horses. Once ingested, they can spend a substantial time as encysted larvae in
the intestinal wall. The larvae can comprise up to 90% of the total burden, with up to several million worms reported in
individuals. These stages can emerge in large numbers to cause life-threatening colitis. Direct methods for detection of
encysted larval burdens in live horses do not exist. Previously, two antigen complexes were identiﬁed as promising
markers for infection. A component of these, cyathostomin gut associated larval antigen-1 (Cy-GALA-1), was identiﬁed
following immunoscreening of a complementary DNA library. Serum immunoglobulin G(T) (IgG(T)) responses to
Cy-GALA-1 were shown to inform on larval infection. Sequence analysis of polymerase chain reaction products
ampliﬁed from individual worms indicated that Cy-GALA-1 was derived from Cyathostomum pateratum. As cyathostomin
infections always comprisemultiple species, a diagnostic test must account for this. Here, segments of theCy-gala gene were
isolated from four common species, Cyathostomum catinatum, Cylicocyclus ashworthi, Cylicostephanus goldi and
Cylicostephanus longibursatus, and the associated proteins expressed in recombinant form. The speciﬁcity and immunogen-
icity of each protein was conﬁrmed. Each protein was assessed by enzyme linked immuno sorbent assay (ELISA) for its
ability for informing on the presence of encysted larval infection and the level of burden.
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INTRODUCTION
Parasitic nematodes of the group Cyathostominae
are a potential cause of serious disease in equids.
These parasites have a high prevalence and most
horses that graze encounter them (Matthews,
2008). Cyathostomins exist as a group of around 50
species (Lichtenfels et al. 2008); however, most
infections comprise 5–10 common species, with
low numbers of rarer species present (Chapman
et al. 2002a). Species compositions are similar
across regions, with the same group appearing as
the most prevalent globally (Ogbourne, 1976;
Reinemeyer et al. 1984; Mﬁtilodze and
Hutchinson, 1990; Bucknell et al. 1995; Gawor,
1995; Lichtenfels et al. 2001; Collobert-Laugier
et al. 2002). For all species, the life cycle involves
larval encystment in the wall of the large intestine
and larvae can persist for up to 2 years (Gibson,
1953; Smith, 1976; Murphy and Love, 1997). In
some horses, encysted larvae can constitute up to
90% of the total burden, with some individuals har-
bouring millions of worms (Dowdall et al. 2002).
Encysted larvae are important in the pathogenesis of
cyathostomin infections, because these stages can
emerge in great numbers to cause larval cyathostomi-
nosis, a colitis syndrome that can be fatal in up to
50% of cases (Giles et al. 1985; Love et al. 1992).
Larval cyathostominosis is most commonly observed
in horses of 2–5 years of age (Reid et al. 1995);
however, animals can have a lifelong susceptibility to
infection and disease has been observed in horses of
all ages (Mair, 1993). The potential clinical eﬀects of
cyathostomins are confounded by high levels of anthel-
mintic resistance in these nematodes, with resistance to
benzimidazole and pyrantel compounds almost ubi-
quitous in some regions (Kaplan, 2002; Matthews,
2014). The macrocyclic lactones are the most com-
monly used anthelmintics in horses and reduced
eﬃcacy against cyathostomins has been reported for
ivermectin in Brazil (Canever et al. 2013), with
several studies reporting shortened strongyle egg† These authors contributed equally to this work.
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reappearances period following ivermectin (Geurden
et al. 2014; Relf et al. 2014) and moxidectin
(Rossano et al. 2010; Relf et al. 2014) treatment. A
shortened helminth egg reappearance period is
regarded as an early indicator of resistance (Sangster,
1999), highlighting the threat of resistance to all avail-
able classes of broad spectrum anthelmintic.
Anthelmintic targeting of encysted larvae is now
common practice in control programmes in some
regions (Stratford et al. 2014). Moxidectin and fen-
bendazole (administered over 5 consecutive days)
are registered for this purpose (Matthews, 2008);
however, because of high levels of resistance to fen-
bendazole (Reinemeyer et al. 2016), moxidectin is
the only remaining compound eﬀective against
encysted larvae, so its eﬃcacy needs to be preserved.
To address this, a reduction in treatment frequency
is recommended (Matthews, 2014). This can be
achieved by improving grazing practices to reduce
transmission via the environment, combined with
speciﬁc targeting of treatments based on strongyle
egg shedding (Nielsen et al. 2006, 2014; Lester and
Matthews, 2014). Such protocols do not address
encysted larvae within individuals. Indeed, horses
with sizeable encysted larval burdens often have no
or low egg shedding (Dowdall et al. 2002). Because
of these issues, a test that informs on the presence
or burden of encysted larvae would facilitate anthel-
mintic targeting of these stages and would assist in
the deﬁnitive diagnosis of larval cyathostominosis, a
challenge in practice due to the non-speciﬁc nature
of the associated clinical signs (Giles et al. 1985).
Previously, these authors identiﬁed two native
antigen complexes that showed promise as diagnostic
markers of encysted larval infection (Dowdall et al.
2002, 2003, 2004). The antigen preparations are
labour intensive to prepare and rely on a continual
source of equine tissue. Thus, steps were taken to
identify genes that encode protein components of
the complexes to develop a recombinant protein-
based test. One component, cyathostomin gut asso-
ciated larval antigen-1 (Cy-GALA-1) protein, was
identiﬁed by immunoscreening a larval complemen-
tary (c)DNA library using sera from infected ponies
(McWilliam et al. 2010). Sequence analysis of poly-
merase chain reaction (PCR) products ampliﬁed
from DNA from individual worms indicated that
Cy-GALA-1 was derived from the common species,
Cyathostomum pateratum, so Cy-GALA-1 was re-
designated Cy-GALA-pat (McWilliam et al. 2010).
Recombinant Cy-GALA-pat was demonstrated to be
the target of serum immunoglobulin G(T) (IgG(T))
responses in infected, but not in uninfected horses,
and exhibited no reactivity to antibody in serum from
horses speciﬁcally infected with non-cyathostomin hel-
minths. In experimentally- and naturally-infected
horses, antigen-speciﬁc IgG(T) levelswere signiﬁcantly
higher than those in cyathostomin negative animals,
with antigen-speciﬁc IgG(T) levels shown to have a
signiﬁcant positive correlation with encysted larval
burden (McWilliam et al. 2010). As horses invariably
harbour a range of cyathostomin species, a diagnostic
test will need to take account of this complexity. Here,
recombinant GALA proteins were generated from
four common cyathostomin species and the speciﬁcity
and immunogenicity of each examined. These proteins
were assessed by the enzyme linked immuno sorbent
assay (ELISA) for their ability to predict the presence
of encysted larval infection and the level of burden.
MATERIALS AND METHODS
Parasite material
Individual adult cyathostomins were removed from
the large intestinal luminal contents of naturally-
infected horses at post mortem (Dowdall et al.
2002). The worms were identiﬁed to species by mor-
phological means based on the key of Lichtenfels
et al. (2008). Cyathostomin encysted larvae were
recovered by pepsin-hydrochloric (HCl) digestion
or by manual removal from the mucosa and sub-
mucosa as described previously (Dowdall et al. 2002).
Serum samples
For immunoblotting and ELISA experiments, sera
from diﬀerent sources were used to examine the spe-
ciﬁcity and immunogenicity of each recombinant
protein. First, sera were used from six ponies that
had been raised in helminth free (HF) conditions in
the UK. Three of these ponies (Ponies 102, 103,
106) were maintained HF until necropsy and the
remaining three (Ponies 101, 104, 105), were sub-
jected to a ‘trickle’ infection regimewith cyathostomin
third stage larvae as described previously (Murphy
and Love, 1997). The sera from these ponies were
used as a source of cyathostomin negative control
sera (classiﬁed here as HF) and cyathostomin positive
control sera (classiﬁed here as cyathostomin infected,
CI). A CI serum pool comprised samples from the
three experimentally infected ponies taken at 12–16
weeks post-infection. These time points were selected
on the basis of high serum IgG(T) reactivity in these
ponies to native encysted larval antigen complexes
identiﬁed in Dowdall et al. (2002). A pool of negative
control serum was prepared from samples obtained
from the three HF ponies. These serum pools were
used as controls in all subsequent immunoblotting
and ELISA studies. Serum was also available to
examine, by immunoblotting, the cross reactivity of
the GALA recombinant proteins to those present in
other nematode species. In these studies, sera from
horses infected with Strongylus edentatus or
Strongylus vulgaris (Klei et al. 1982) or with
Parascaris equorum or Strongylus westeri (Dowdall
et al. 2003) were used. To assess and measure the
immunogenicity of the recombinant proteins, serum
was used that was derived from naturally or
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experimentally infected horses from the UK and
USA. For some of these groups, enumerated nema-
tode burden data were available, which allowed com-
parison of antigen speciﬁc IgG(T) levels with level of
burden. For immunoblotting studies, serum IgG(T)
reactivity was assessed in a serum pool from seven nat-
urally-infected horses from the UK, each of which
had a high total mucosal burden (TMB) of >100 000
encysted larvae (Dowdall et al. 2002). In the immuno-
blotting studies, serum IgG(T) reactivity was also
assessed in a pool of sera obtained from 11 clinical
cases of larval cyathostominosis. These horses were
classiﬁed as clinical cases based on their presenting
signs and the detection of large numbers of cyathosto-
min larvae in their faeces (Hodgkinson et al. 2003).
Rabbit sera were also used in the immunoblotting
studies. Here, sera raised to the native antigen
complex (Dowdall et al. 2003) and to Cy-GALA-pat
(McWilliam et al. 2010) were used. Antigen reactivity
in rabbit serum obtained before and after immunisa-
tion was compared. In the ELISA studies, serum
samples from individuals from various populations
were tested for reactivity to each GALA protein.
First, sequential serum samples from the six experi-
mental ponies (above) were used in time course
experiments to measure levels of antigen speciﬁc
IgG(T) in each pony from before infection until 16
weeks after the start of the ‘trickle’ infection.
Antigen speciﬁc IgG(T) levels were also measured
in a group (UK+) of horses that comprised 25
horses sampled at a UK abattoir (Dowdall et al.
2004), as well as the three experimentally infected
ponies as described above (Murphy and Love,
1997). Cyathostomin burdens in these horses were
quantiﬁed with the TMB and total worm burden
(TWB) calculated as described previously (Dowdall
et al. 2004). Antigen-speciﬁc serum IgG(T) levels
were also measured in each of the 11 larval cyathosto-
minosis cases from the UK (UK+Clin). Serum IgG
(T) levels in these cohorts were compared with those
in serum obtained from the six experimental ponies
before infection (UK-, Murphy and Love, 1997).
Several groups of CI horses from the USA (US+)
were also assessed for serum IgG(T) levels to each
antigen. One group comprised 10 naturally-infected
horses (Monahan et al. 1996). Another comprised 38
ponies subjected to various cyathostomin experimen-
tal infection/treatment regimens (Monahan et al.
1997, 1998; Chapman et al. 2002b). Serum IgG(T)
levels in these cohorts were compared with those in
US cyathostomin free ponies that were infected with
S. vulgaris, P. equorum and S. westeri (US−).
Sub-cloning and recombinant protein expression of Cy-
Gala proteins from an additional four cyathostomin
species
Like Cy-GALA-pat, two of the additional
proteins were derived from clones selected by
immunoscreening (McWilliam et al. 2010). Similar
to the strategy used to ascribe a species identity to
Cy-gala-pat, nucleotide sequences in these two
clones were compared with gala sequences obtained
by polymerase chain reaction (PCR) ampliﬁcation
from individual identiﬁed worms of various species.
Based on this analysis, the clones were ascribed to
the common species, Cylicocyclus ashworthi (sequence
named as Cy-gala-ash) and Cyathostomum catinatum
(sequence named as Cy-gala-cat). For recombinant
protein expression, Cy-gala-ash and Cy-gala-cat
sequences were used to design primers to facilitate
PCR ampliﬁcation of Cy-gala encoding sequence
(minus the signal peptide sequence) from phage
plaque eluates from respective clones selected by
immunoscreening (McWilliam et al. 2010).
Sequences encoding restriction enzyme sites were
incorporated into each primer to facilitate unidirec-
tional cloning [the nucleotide sequences reported in
this paper have been submitted to GenBank, accession
numbers: JN596964 (Cy-gala-ash), JN596966
(Cy-gala-cat), JN596967 (Cy-gala-gol), JN596968
(Cy-gala-lon)]. The primer sequences were: Cy-gala-
ash (SacI, NotI sites underlined) sense 5′-
ATTCGAGCTCCCATGAAGAACTTC
GTCGTCAC-3′, antisense 5′-AGCTTGCGGC
CGCATATCTTCTATCCGTGTTGAG-3′; Cy-
gala-cat (NcoI, NotI sites underlined) sense 5′-
ATGGCCATGGATGAGGATCGTGAAGAAC
ATCGC-3′, antisense 5′- AGCTTGCGGCCGC
ATCTCTTTCATCTGTGTTGAGTCC-3′. The
PCR conditions were as follows: 0·5 µM primers,
0·2 mM dNTPs and 1·5 mM MgCl2, with cycling
conditions, 94 °C for 2 min, 30 cycles at 94 °C for
15 s, with an annealing temperature of 54 °C (Cy-
gala-ash) or 53 °C (Cy-gala-cat) for 30 s, and 72 °C
for 60 s, with a ﬁnal cycle of 72 °C for 7 min.
Ampliﬁcations were performed using Platinum
Taq (Invitrogen) in combination with 2 µL of each
phage plaque eluate in a reaction volume of 50 µL.
For size determination, PCR products were analysed
on 1·1% w/v agarose TAE gels using a TrackIt 100
bp DNA Ladder (Invitrogen) and stained with 1×
GelRed (Biotium). Next, the expression plasmid
(pET-22b(+), Novagen) and each PCR product were
digested with the appropriate restriction enzymes
and ligation of the PCR amplicons performed using
T4 ligase (Promega). The derived plasmids were
transformed into Escherichia coli JM109 competent
cells (Promega) and selected on ampicillin-Luria-
Bertani (LB) agar. For each species, one colony
containing plasmid with an insert of the correct size
was subjected to plasmid puriﬁcation (Wizard Plus
SV Miniprep kit, Promega) and the insert sequenced
in full to conﬁrm identity. On conﬁrmation of
sequence identity, plasmids were transformed into
E. coli BL21-CodonPlus(DE3)-RIL competent
cells (Stratagene) for expression of recombinant
Cy-GALA-ash and Cy-GALA-cat. Recombinant
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protein expression was induced as described in
McWilliam et al. (2010). Similar to Cy-GALA-pat
(McWilliam et al. 2010), Cy-GALA-cat was soluble
and present in the bacterial lysate supernatant.
This protein was puriﬁed directly on a HisTrapHP
column (GEHealthcare), eluted in increasing concen-
trations of imidazole, then dialysed with 20 mM
sodium phosphate, 0·5 M NaCl (pH 7·4), and stored
at −20 °C. The Cy-GALA-ash protein was insoluble,
so puriﬁcation and dialysis were carried out as above,
with the exception that 8 M urea was added to all
buﬀers.
For isolation of gala sequences from
Cylicostephanus goldi and Cylicostephanus longibursa-
tus, conserved primers (sense 5′-ATGAACAAA
ACGTTAACATTTCTC-3′, antisense 5′-AGGAG
GTGATGATGGCATG-3′) were designed using
all of the gala sequences described above and used
to PCR-amplify a portion of the gala gene from
single, identiﬁed adult C. goldi and C. longibursatus
using cDNA synthesized as described in Lake et al.
(2009). The PCR products were cloned into
pGEM®-T Easy vector (Promega), plasmid prepara-
tions made and the inserts sequenced in both direc-
tions. To generate PCR products for sub-cloning
for protein expression, species-speciﬁc primers were
designed using the C. longibursatus and C. goldi
sequences obtained from individual identiﬁed
worms. For each, primer sequences (SacI and NotI
restriction sites underlined) were: Cy-gala-gol sense
5′-ATTCGAGCTCCCAAGGTGTCATGGCCC
TATTTG-3′, antisense 5′-ATTAGCGGCCG
CCAGGTATCTTCTATCCGTGTTCAG-3′, and
for Cy-gala-lon sense 5′-ATTCGAGCTCCCAAG
GTGTCATGGACCTTTTTGG-3′, antisense 5′-
ATTAGCGGCCGCATATCTTCTATCCGTGT
TGATTCCG-3′. PCR conditions were as above,
except that 0·25 µM primers and 0·4 µL of Platinum
Taq were used in reaction volumes of 100 µL, and
30 ampliﬁcation cycles performed with an annealing
temperature of 58 °C. The PCR products and vector
were digested with SacI (Promega) and NotI
(Promega) and ligated into pET-22b(+) vector.
Plasmids were transformed into E. coli JM109
Competent Cells (Promega) and selected on ampicil-
lin-LB agar. Colonies were examined by PCR for
the presence of an insert of the correct estimated size
using vector-speciﬁc primers and plasmid prepara-
tions made from two colonies, which were sequenced
using the same primers. Clones of the correct sequence
were transformed into BL21-CodonPlus(DE3)-RIL
cells as above. Recombinant Cy-GALA-lon and Cy-
GALA-gol were insoluble, so were prepared and
stored in the presence of 8 M urea as above.
Nucleotide and amino acid sequence alignments
were performed using ClustalW2 (Larkin et al. 2007)
and sequence identity levels examined using
MegAlign 10·0·1 (DNASTAR) based on the
ClustalW2 alignments. Signal peptides were identiﬁed
using SignalP 4·0 (Petersen et al. 2011). Sequences
were translated and molecular mass estimated using
the Sequence Manipulation Suite (http://www.bio
informatics.org/sms2/protein_mw.html).
Immunogenicity and speciﬁcity of recombinant GALA
proteins assessed by immunoblotting
To assess immunogenicity and potential cross re-
activity of each recombinant protein, binding of
IgG(T) in sera from horses infected only with
cyathostomins or with single-species experimental
infections of non-cyathostomin helminths was inves-
tigated (for serum sources, see above). Serum IgG
(T) reactivity was also assessed in serum pooled
from naturally-infected horses from the UK (UK+)
and in a pool of sera from larval cyathostominosis
cases (UK+Clin). Finally, IgG reactivity in rabbit
sera raised to a 20 kDa larval antigen complex and
to recombinant Cy-GALA-pat (see above) were
assessed. For blotting, 0·1 µg of each GALA
protein was loaded, per lane, onto a 15-well, 12%
NuPAGE gel with SeeBlue Plus2 protein standards
used for size estimations (Invitrogen). An additional
lane was loaded with 0·1 µg protein. After electro-
phoresis, this lane was removed and stained with
Coomassie blue for comparison with the immuno-
blots. Blocking, primary, secondary and tertiary anti-
body steps and blot development were as described
in McWilliam et al. (2010).
Immunoreactivity of the recombinant GALA proteins
assessed by ELISA
Once the immunogenicity and speciﬁcity of each
new GALA protein was conﬁrmed by immunoblot-
ting, the ELISA was used to evaluate serum IgG(T)
levels to each protein in various groups of equids (see
above). First, IgG(T) levels to the GALA proteins
were assessed in ponies over a time course of experi-
mental infection (Murphy and Love, 1997).
Antigen-speciﬁc IgG(T) levels were then assessed
in cohorts of horses from the UK (UK+) and from
the USA (US+) for which the cyathostomin
burden was known and in a cohort of larval cyathos-
tominosis cases (see above). Serum IgG(T)
responses to Cy-GALA-pat were compared in
these studies. The ELISA plates (96-well ﬂat bot-
tomed Microlon High binding plates, Greiner Bio-
One) were coated with recombinant GALA antigens
at 2 µg mL−1. Each well was coated with 100 µL of
antigen in coating buﬀer (0·1 M carbonate coating
buﬀer, pH 9·6) overnight at 4 °C. Plates were
washed six times with 0·05% Tween-20 in phosphate
buﬀered saline (PBS) (PBS-T), then blocked using
200 µL block buﬀer (2% soya powder (Infasoy™
Cow and Gate Ltd), w/v in PBS), per well for 1 h
at 37 °C. All serum dilutions were made in block
buﬀer. The plates were washed three times (as
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above) and 100 µL sera (diluted 1:800) added to each
well and incubated for 2 h at 37 °C. Each serum
sample was tested in triplicate. Plates were washed
six times, incubated for 1 h with (100 µL per well)
goat anti-equine IgG(T) whole molecule (Serotec),
diluted 1:400 in block buﬀer. The plates were
washed six times, then 100 µL rabbit anti-goat Ig:
HRP conjugate (Sigma), diluted 1:500 in block
buﬀer, added to each well and incubated for 1 h at
37 °C. Reactions were developed by adding 100 µL
o-Phenylenediamine dihydrochloride (OPD) solution
prepared from SIGMAFAST OPD tablets (Sigma)
to each well. After 15 min at room temperature, 50
µL 2·5 M H2SO4 were added to stop the reactions
and the absorbance in each well read at 490 nm. On
all plates, aliquots from the same pool of CI sera
were tested in triplicate as a control for inter-plate
variation. The results derived from all samples were
then expressed as the percentage optical density
(OD) of the CI sample mean for each plate. Minitab
17 Statistical Software for Windows was used to
analyse the data. For the diﬀerent infected groups
(UK+, UKClin+, US+), the group medians of the
percentage positivity were compared with those of
the cyathostomin free horses (UK− and US−) by
the Mann–Whitney test. A P value <0·05 was taken
to indicate statistical signiﬁcance.
Receiver operator characteristic (ROC) curve analysis
ROC curve analysis was performed to indicate the
accuracy of each GALA protein ELISA result relat-
ing to cyathostomin infection (postive or negative)
and to cyathostomin TMB and TWB by assessing
the tradeoﬀ of diagnostic sensitivity vs speciﬁcity
over a range of cut-oﬀ values. As an estimate of
test accuracy, the area under the curve (AUC) may
be interpreted such that; AUC= 0·9–1·0 demon-
strates an excellent level of discrimination between
positive and negative results; AUC= 0·8–0·9 good
discrimination; AUC= 0·7–0·8 fair discrimination;
AUC= 0·6–0·7 poor discrimination and AUC=
0·5–0·6 no discrimination (Swets, 1988). All
ELISA data were subjected to ROC analysis using
Prism 6 (Graphpad Software Inc, USA).
RESULTS
Analysis of GALA sequences from the four additional
cyathostomin species
Alignment (Fig. 1) of the derived GALA protein
sequences demonstrated that, like Cy-GALA-pat,
all sequences from the additional four species con-
tained an N-terminal histidine-rich motif and a
highly-conserved domain (Marchler-Bauer et al.
2007), the function of which is unknown and
which is termed as Domain of Unknown Function
148 in the two most closely related sequences from
Caenorhabditis elegans. Comparative analysis
(Table 1) indicated that the sequences were
between 83·3% (Cy-GALA-ash) and 92·9% (Cy-
GALA-cat) identical to Cy-GALA-pat at the
amino acid level. The level of intra-speciﬁc identity
in the derived amino acid sequences was higher
than 90% for all ﬁve species examined.
Immunoreactivity and cyathostomin speciﬁcity of the
recombinant GALA proteins
Coomassie staining of the four new recombinant
GALA proteins (Fig. 2A) demonstrated that the ap-
proximate size observed for each corresponded to the
calculated molecular mass. The immunoblot experi-
ments demonstrated that IgG(T) in sera from HF
ponies did not bind to any of the four recombinant
GALA proteins, whilst IgG(T) in sera from ponies
experimentally infected with cyathostomins (CI
sera) bound to all four (Fig. 2B). In terms of cross re-
activity to other helminth species, there was no, or
negligible, IgG(T) binding to each of the four re-
combinant GALA proteins observed in sera from
horses infected speciﬁcally with P. equorum,
S. edentatus, S. vulgaris or S. westeri (Fig. 2B). To
further examine immunogenicity of the proteins in
naturally-infected horses, immunoblots were per-
formed using sera pooled from horses that presented
at an abattoir and which had high encysted larval
burdens. Here, strong reactivity of IgG(T) to all
four GALA proteins was observed (Fig. 3A).
Likewise, IgG(T) in sera pooled from samples
from larval cyathostominosis cases demonstrated
strong reactivity to all proteins (Fig. 3B). The
GALA proteins also bound IgG in sera from a
rabbit immunised with the native 20 kDa complex,
originally identiﬁed in encysted larvae (Dowdall
et al. 2003, Fig. 3C). Similarly, IgG in sera from a
rabbit immunised with Cy-GALA-pat bound each
of the four new recombinant GALA proteins
(Fig. 3D). No binding was observed in pre-immun-
isation sera from either rabbit.
ELISA and ROC curve analysis of serum IgG(T)
responses to the recombinant GALA proteins in CI
horses
A time course study was performed to analyse serum
IgG(T) responses to each new GALA protein in ex-
perimentally-infected ponies across a trickle infec-
tion (Fig. 4). IgG(T) responses in infected ponies
(Ponies 101, 104, 105) were analysed from before in-
fection until 16 weeks after ﬁrst challenge. GALA-
speciﬁc IgG(T) in these individuals were compared
with those in ponies that remained uninfected
(Ponies 102, 103, 106). Similar to previous observa-
tions with GALA-pat (McWilliam et al. 2010),
increases in antigen-speciﬁc IgG(T) were observed
against all recombinant GALA proteins after
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infection; however, the dynamics of the repsonse to
each varied amongst individuals. Serum IgG(T)
responses to GALA-ash, lon and gol proteins
increased more rapidly in Pony 104 than in the
other two infected ponies. This was not the case
with respect to responses to the GALA-cat protein,
against which IgG(T) levels increased more slowly
than to the other proteins. In Pony 104, IgG(T)
levels to GALA-ash, gol and lon plateaued after 7
weeks post-infection and remained high until the
end of the time course. Antigen-speciﬁc IgG(T)
levels in Ponies 101 and 105 increased at a slower
rate, but generally reached similar levels to those
measured in Pony 104 by the end of the time
course, with the exception of Pony 101’s IgG(T) re-
sponse to GALA-cat. Increases in antigen-speciﬁc
IgG(T) levels were not observed in any of the HF
ponies across the time course.
Next, levels of serum IgG(T) to all four new
GALA proteins and GALA-pat were compared in
equids for which cyathostomin burden data were
available, thus allowing comparison of parasitologic-
al parameters with speciﬁc IgG(T) levels in matched
end-point serum samples. Also analysed were
GALA-speciﬁc serum IgG(T) responses in horses
that presented with larval cyathostominosis. First,
serum IgG(T) levels were compared in CI groups
(UK+, US+, UKClin+) with those in cyathostomin
negative groups (UK−, US−) from the UK and the
USA. For the UK+ and UKClin+ cohorts, for all
ﬁve proteins, speciﬁc IgG(T) levels were signiﬁ-
cantly higher than in cyathostomin negative horses
Fig. 1. ClustalW alignment of Cy-GALA-pat with its orthologues in other cyathostomin species. Cy-GALA-pat
(Accession Number: FJ882059) is aligned with GALA proteins from four additional cyathostomin species, Cylicocyclus
ashworthi (Accession number, JN596964), Cyathostomum catinatum (Accession number, JN596966), Cylicostephanus
longibursatus (Accession number, JN596968) and Cylicostephanus goldi (Accession number, JN596967). The domain of
unknown function (DUF148) is boxed. The histidine-rich region is highlighted in grey.
Table 1. Details of GALA sequences representing recombinant proteins used in the ELISA
GALA protein
name
Number of worms sequenced per
species (range of intraspeciﬁc variation
in amino acid sequence as a percentage)
Amino acid identity (%) to
Cy-GALA-pat sequence of
each clone used for expression
Predicted size of
recombinant protein
including His tag (kDa)
ash 3 (95·5–97·2) 83·3 25·5
cat 4 (92·9–97·3) 92·9 25·1
gol 4 (90·8–100) 91·3 27·2
lon 2 (97·1–100) 89·8 27·0
pat 5 (94·7–97·6) 100 26·6
These are derived from the species:Cylicocyclus ashworthi (ash),Cyathostomum catinatum (cat),Cylicostephanus goldi (gol),
Cylicostephanus longibursatus (lon) and Cyathostomum pateratum (pat).
Accession numbers of the sequences representative of each clone used for expression for each species are as follows: Cy-
gala-pat – FJ882059·1, Cy-gala-cat – JN596966, Cy-gala-gol – JN596967, Cy-gala-lon – JN596968, Cy-gala-ash –
JN596964.
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(Table 2). Likewise, for the US population, levels of
IgG(T) to each protein were signiﬁcantly higher in
the US+ group than in the US− (cyathostomin
free) group. ELISA data from horses for which
cyathostomin burdens were available were subjected
to ROC curve analysis. For all ﬁve proteins, GALA-
speciﬁc IgG(T) levels in equids, which were known
to be truly cyathostomin negative (i.e. the UK− and
US− groups) were compared with GALA-speciﬁc
IgG(T) levels measured in CI horses from the UK
or the US (Table 3). Here, high AUC values (i.e.
>0·9) were obtained for all proteins (AUC values:
‘ash’ and ‘lon’> ‘pat’> ‘cat’> ‘gol’). The highest
sum of percentage sensitivity and speciﬁcity values
generated here were then used to calculate cut-oﬀ
percentage positivity thesholds for each GALA
protein (Table 3). Based on these values, speciﬁcity
ranged from 82·43% (ash) to 95·95% (cat) and
sensitivity from 77·78% (cat, gol) to 100% (ash and
pat). When the data were stratiﬁed at diﬀerent
cyathostomin TMB thresholds, taking into account
that some horses negative for TMB were positive
for cyathostmin luminal parasites (Table 4), AUC
values and sensitivity and speciﬁcity values
Fig. 2. Speciﬁcity of the four recombinant GALA
proteins. (A) Coomassie stained sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) gel
depicting all four new recombinant GALA proteins. ash =
C. ashworthi recombinant protein; cat =C. catinatum
recombinant protein, gol =C. goldi recombinant protein,
lon =C. longibursatus recombinant protein, M=molecular
weight marker. (B) Immunoblots of each recombinant
protein (Cy-GALA-ash, -cat, -gol and -lon) probed for
IgG(T) reactivity using sera from helminth free (HF)
ponies, experimental cyathostomin infected (CI) ponies
and horses infected speciﬁcally with Parascaris equorum
(Pe), Strongylus edentatus (Se), Strongyloides westeri (Sw)
or Strongylus vulgaris (Sv). M=molecular weight marker.
Fig. 3. Immunogenicity of the recombinant GALA
proteins. (A) Immunoblot of each recombinant protein
(Cy-GALA-ash, -cat, -gol and -lon) probed for binding of
IgG(T) in a pool of serum from UK naturally infected
horses, each of which had a total cyathostomin encysted
larval burden of >100 000 larvae. (B) Immunoblot of each
recombinant protein (Cy-GALA-ash, -cat, -gol and -lon)
probed for binding of IgG(T) in a pool of serum from
larval clinical cyathostominosis cases from the UK. (C)
Immunoblot of each recombinant protein (Cy-GALA-
ash, -cat, -gol and -lon) probed for binding of IgG in sera
from a rabbit taken before (P) and after (I) immunization
with the cyathostomin encysted larval 20 kDa complex
(Dowdall et al. 2003). (D) Immunoblot of each
recombinant protein (Cy-GALA-ash, -cat, -gol and -lon)
probed for binding of IgG in sera from a rabbit taken
before (P) and after (I) immunization with Cy-GALA-pat
(McWilliam et al. 2010).
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calculated were lower. Next, TWB thresholds were
examined to assess if the outputs were likely to be
confounded by the half life of GALA-speciﬁc
serum IgG(T) responses; for example, in equids
where there had been recent emergence of previous-
ly-encysted larvae or in those that had been adminis-
tered recently with an eﬀective larvicidal treatment.
When the cohort was stratiﬁed on the basis of
cyathostomin TWB, for all proteins, AUC and sen-
sitivity and speciﬁcity values were higher than when
the group was stratiﬁed on the basis of TMB alone
(Table 4). For ‘0 TWB’ threshold, AUC values for
IgG(T) responses to all ﬁve GALA proteins were
high (i.e. >0·9). Finally, the cohort was statﬁed on
the basis of a threshold of 5000 mucosal larvae or
TWB. At a cutoﬀ of a TMB of 5000 larvae, AUC
values ranged from 0·69 (GALA-ash) to 0·77
(GALA-cat), so giving ‘good’ discrimination. At a
cutoﬀ of 5000 TWB, GALA-cat and GALA-lon
(AUC values for both = 0·82) gave the highest
values, with AUC values for the other protiens
exceeding 0·7. When the data were partitioned
such that the threshold value was 10 000 TMB or
TWB, most AUC values generated were <0·7 (data
not shown).
DISCUSSION
Cyathostomins have high pathogenic potential in
equids due to their capacity to cause life-threatening
colitis when encysted larvae emerge from the intes-
tinal wall. For this reason, the administration of
anthelmintics that have activity against these devel-
opmental stages is regarded by many as an essential
component of equine parasite control programmes
in developed regions (Nielsen, 2012; Matthews,
2014; Nielsen et al. 2014). As it is likely that most
horses will not carry life-threatening levels of
encysted larvae, the availability of a diagnostic test
that can inform on the presence or burden of these
stages would help in directing the strategic applica-
tion of larvicidal anthelmintic treatments.
Fig. 4. IgG(T) responses in experimentally infected ponies to the four recombinant GALA proteins as measured by the
ELISA. Recombinant GALA (A. GALA-ash, B. GALA-cat, C. GALA-gol, D. GALA-lon) protein-speciﬁc IgG(T)
responses over an experimental trickle infection (Murphy and Love, 1997). Six British native-breed ponies (6–12 months
at the time of initial infection) were reared indoors with their dams and considered to be helminth naive prior to the start of
the trial. Following weaning at 4 months, the ponies were maintained on a high-ﬁbre pelleted ration and bedded on wood
shavings. Three ponies (Ponies 101, 104 and 105) were infected with a total of 3·9 million cyathostomin third stage larvae
(L3), administered as a trickle infection of 150 000 L3 by nasogastric tube, three times a week. Ponies 102, 103 and 106
were maintained as uninfected controls. Pony 104 was necropsied at 20 weeks post-infection and the remaining ponies at
60–62 weeks post-infection.
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The development of a diagnostic test for cyathos-
tomins is complicated by the complex nature of this
group of nematodes. There are 50 recognized
cyathostomin species (Lichtenfels et al. 2008);
however, whilst a range of species is found in indivi-
duals, the majority of the burden has been found
consistently across geographic regions to comprise
5–10 common species. The species investigated
here were selected on the basis that they were the
most prevalent species identiﬁed across multiple
studies. In particular, C. longibursatus and C. catina-
tum are regularly recorded as the commonest species
recovered from horses (Krecek et al. 1989 [South
Africa]; Mﬁtilodze and Hutchinson, 1990
[Tropical Australia]; Bucknell et al. 1995 [Victoria,
Australia]; Gawor, 1995 [Poland]; Lichtenfels et al.
2001 [UK], Chapman et al. 2002a [USA]; Boxell
et al. 2004 [Western Australia]; Kuzmina et al.
2005 [Ukraine]). A representative protein for C. ash-
worthi was also selected here. This species has been
regarded as a synonym of Cylicocyclus nassatus; the
two are similar morphologically but are now
regarded as separate (Lichtenfels et al. 1997).
Earlier studies may have misidentiﬁed C. ashworthi
(Chapman et al. 2002a), so this species may have
been under-represented. Indeed, where C. ashworthi
has been deﬁned as distinct from C. nassatus, it has
been found at high prevalence (Lichtenfels et al.
2001; Kuzmina et al. 2005; Kornas ́ et al. 2009).
Likewise, C. goldi and C. pateratum are species
detected in high abundance in surveys performed
in diﬀerent regions (Reinemeyer et al. 1984;
Krecek et al. 1989; Mﬁtilodze and Hutchinson,
1990; Gawor, 1995; Collobert-Laugier et al. 2002;
Boxell et al. 2004; Traversa et al. 2010). As there
does not appear to have been an obvious shift in
the prevalence ranking of cyathostomin species
over time, despite the advent and spread of anthel-
mintic resistance (Chapman et al. 2002a), it is with
conﬁdence that inclusion of the species here re-
present common components of cyathostomin infec-
tions now, as well as in the future.
The level of intra-speciﬁc variation observed in the
GALA sequence was low in all species studied
(Table 1). Further, the diversity observed in GALA
sequence between these species was far lower than
that seen when the GALA sequences were compared
with orthologous sequences present in non-cyathos-
tomin species (data not shown), thus indicating that
the test is unlikely to be aﬀected by cross reactivity
to non-cyathostomin infections. In agreement with
this, the speciﬁcity of each recombinant GALA
protein was conﬁrmed in immunoblotting experi-
ments when each was probed with sera from horses
speciﬁcally infected with large strongyle species, P.
equorum orS. westeri, and no reactivity was observed.
Further immunoblotting experiments demonstrated
that all four GALA proteins bound strongly to IgG
(T) in serum pooled from CI horses and in serum
from clinical cases of larval cyathostominosis. These
results were substantiated by the ELISA data,
which demonstrated signiﬁcantly higher speciﬁc
serum IgG(T) levels to each GALA protein in the
USA and UKCI groups compared with the respect-
ive cyathostominnegative groups (Table 2).The time
course study supported these ﬁndings, demonstrat-
ing robust anti-GALA serum IgG(T) responses in
all infected ponies. Similar to previous results
obtained with Cy-GALA-pat (McWilliam et al.
2010) and with native antigens (Dowdall et al.
2002), speciﬁc IgG(T) increased to GALA-ash, -gol
and -lon in Pony 104 earlier than in the other infected
ponies. Themore severe clinical parameters observed
in Pony 104 indicated that it had developed the great-
est burden of mucosal larvae during the infection
protocol and, when this animal was euthanized (at
20 weeks post-infection), it was found to have a
very high (>700 000 cyathostomin larvae) burden
(Murphy and Love, 1997). The other two ponies
had substantially lower burdens, but they were not
necropsied until 60 and 62 weeks post-infection.
The diﬀerences in the dynamics in IgG(T) response
to theGALA-cat proteinmay reﬂect the relative pro-
portions in species present over the trickle infection
period (Murphy and Love, 1997). The observations
Table 2. Comparison of serum IgG(T) levels in
cyathostomin-infected vs non-infected groups from
the UK and USA
Groups compared
GALA
protein P value
UK+ (n= 26) vs UK− (n= 6) ash 0·0007
cat 0·0011
gol 0·0018
lon 0·0006
pat 0·0006
UKClin+ (n= 11) vsUK− (n= 6) ash 0·0011
cat 0·0077
gol 0·0011
lon 0·0022
pat 0·0104
US+ (n= 48) vs US− (n= 3) ash 0·0172
cat 0·0356
gol 0·0392
lon 0·0213
Pat 0·0192
Horses were naturally infected or subjected to experimen-
tal infection. UK+ comprised 26 cyathostomin naturally-
infected horses sampled at an abattoir. UK− comprised 6
cyathostomin-negative ponies raised helminth-free.
UKClin+ comprised 11 equids with larval cyathostomi-
nosis. US+ (n= 48) comprised natuarally or experimen-
tally infected equids from the USA. US− comprised 3
experimental equids from the US riased cyathostomin-
free. For the infected groups (UK+, UKClin+, US+),
group medians of the percentage positivity were com-
pared with that of cyathostomin-free horses (UK− and
US−) by the Mann–Whitney test. A P value <0·05 was
taken to indicate statistical signiﬁcance.
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here indicate that the long-term goal of this work
should be the development of a test incorporating
several GALA proteins derived from the commonest
species due to the potential risk of false negative
results in some individuals in which a single species
may be less abundant.
The ROC AUC values indicate that all proteins
provide excellent discriminatory information when
comparing true cyathostomin negative with true
cyathostomin postive individuals (Table 3). The
AUC values obtained were similar for all ﬁve
GALA proteins. When horses were stratiﬁed on
the basis of mucosal larval burden (Table 4), the
derived ROC AUC values were lower than the
values obtained when the true cyathostomin nega-
tive group was compared with the cyathostomin
positive horses. This is likely due to the fact that
some horses in the TMB-negative group harboured
Table 3. Receiver operator characteristic (ROC) curve analysis of ELISA data relating to antigen-speciﬁc
IgG(T) levels in horses comparing cyathostomin-positive vs cyathostomin-negative horses
Protein AUC* (95% CI) P value Cut-oﬀ Sensitivity % (95% CI) Speciﬁcity % (95% CI)
ash 0·94 (0·87–0·99) <0·0001 >9·76 82·43 (71·83–90·30) 100·00 (66·37–100·00)
cat 0·91 (0·82–1·01) <0·0001 >5·94 95·95 (88·61–99·16) 77·78 (39·9–97·19)
gol 0·90 (0·82–1·00) <0·0001 >9·24 91·89 (83·18–96·97) 77·78 (39·99–97·19)
lon 0·94 (0·88–1·00) <0·0001 >16·69 75·68 (64·31–84·90) 100·00 (66·37–100·00)
pat 0·93 (0·86–1·00) <0·0001 >7·40 86·49 (76·55–93·32) 88·89 (51·75–99·72)
Horses were naturally infected or subjected to experimental infection. The UK population comprised 26 cyathostomin-
positive and 6 cyathostomin (true) negative equids. The US population comprised 48 cyathostomin-positive and 3
cyathostomin (true) negative equids. The area under the curve (AUC), 95% conﬁdence intervals (CI) and P values for
data generated by ROC curve analysis for each protein are shown. A cut-oﬀ percentage positivity value indicated for
each protein is based on the value calculated as the highest sum of percentage sensitivity and speciﬁcity values obtained
in the ROC analysis.
Table 4. Receiver operator characteristic (ROC) curve analysis of ELISA data relating to antigen-speciﬁc
IgG(T) levels in horses from the UK and USA at various thresholds of larvae in the mucosa (total mucosal
burden, TMB) and of larvae in the mucosa plus lumen (total worm burden, TWB)
Protein AUC* (95% CI) P value Cut-oﬀ
Sensitivity% (95%
CI) Speciﬁcity% (95% CI)
TMB 0 larvae; Negatives: 17,
Positives: 66
ash 0·72 (0·57–0·87) 0·006 >8·88 87·88 (77·51–94·62) 52·94 (27·81–77·02)
cat 0·74 (0·58–0·89) 0·003 >6·72 92·42 (83·20–97·49) 52·94 (27·81–77·02)
gol 0·72 (0·577–0·87) 0·004 >11·36 78·79 (66·98–87·89) 64·71 (38·33–85·79)
lon 0·76 (0·616–0·89) 0·001 >16·69 77·27 (65·30–86·69) 70·59 (44·04–89·69)
pat 0·73 (0·57–0·89) 0·004 >9·78 74·24 (61·99–84·22) 76·47 (50·10–93·19)
TWB 0 larvae; Negatives: 10,
Positives: 73
ash 0·91 (0·83–0·99) <0·0001 >9·76 82·19 (71·47–90·16) 90·00 (55·50–99·75)
cat 0·92 (0·83–1·00) <0·0001 >6·53 93·15 (84·74–97·74) 80·00 (44·39–97·48)
gol 0·91 (0·82–0·99) <0·0001 >10·11 90·41 (81·24–96·06) 80·00 (44·39–97·48)
lon 0·93 (0·86–0·99) <0·0001 >16·69 76·71 (65·35–85·81) 100·00 (69·15–100·00)
pat 0·92 (0·85–0·99) <0·0001 >9·78 72·60 (60·91–82·39) 100·00 (69·15–100·00)
TMB 5000 larvae; Negatives:
30, Positives: 53
ash 0·69 (0·57–0·81) 0·004 >10·24 83·02 (70·20–91·93) 50·0 (31·30–68·70)
cat 0·77 (0·66–0·88) <0·0001 >11·25 71·7 (57·65–83·21) 76·67 (57·72–90·07)
gol 0·70 (0·58–0·82) 0·002 >20·90 66·04 (51·73–78·48) 70 (50·60–85·27)
lon 0·74 (0·63–0·86) 0·0003 >31·17 60·38 (46·0–73·55) 83·33 (65·28–94·36)
pat 0·74 (0·63–0·86) 0·0002 >9·780 81·13 (68·03–90·56) 66·67 (47·19–82·71)
TWB 5000 larvae;
Negatives: 18, Positives: 65
ash 0·75 (0·61–0·88) 0·0015 >8·880 89·23 (79·06–95·56) 55·56 (30·76–78·47)
cat 0·82 (0·70–0·94) <0·0001 >11·25 66·15 (53·35–77·43) 88·89 (65·29–98·62)
gol 0·79 (0·67–0·91) 0·0002 >19·72 64·62 (51·77–76·08) 83·33 (58·58–96·42)
lon 0·82 (0·71–0·93) <0·0001 >17·89 76·92 (64·81–86·47) 83·33 (58·58–96·42)
pat 0·78 (0·66–0·90) 0·0003 >10·78 64·62 (51·77–76·08) 83·33 (58·58–96·42)
Horses were naturally infected or subjected to experimental infection. The area under the curve (AUC), 95% conﬁdence
intervals (CI), P values, cut-oﬀ values and % sensitivity and speciﬁcity are shown.
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luminal stages of cyathostomins; such horses may
have residual GALA-speciﬁc IgG(T) in their
serum stimulated by recent encysted larval infec-
tion. This observation is unlikely to be due to
cross-reactivity to antigens in luminal worms, as
it was demonstrated previously that GALA
protein and gala transcript could not be detected
in these stages (McWilliam et al. 2010). The
serum half-life of equine IgG(T) has been mea-
sured as 21 days (Sheoran et al. 2000), so a limita-
tion of this test is that, in horses that have had
recent emergence of encysted larvae or have
received a recent eﬀective larvicidal treatment,
GALA-speciﬁc IgG(T) levels will still be elevated.
With this in mind, a future objective will be to
investigate the dynamics of circulating GALA
protein-speciﬁc serum IgG(T) after anthelmintic
treatments known to be eﬀective against encysted
larval stages. This issue is not unique to the
cyathostomin test and is a concern with the com-
mercially-available diagnostic assay for the tape-
worm, Anoplocephala perfoliata, in horses. The
tapeworm diagnostic is also based on the binding
of serum IgG(T) to parasite proteins (Barrett
et al. 2004; Abbott et al. 2008). Despite these con-
cerns, the A. perfoliata ELISA is still regarded as a
useful tool in practice (Kjaer et al. 2007; Abbott
and Barrett, 2008). For these reasons, the test
output must always be interpreted alongside the
clinical and treatment history of the individual or
population of animals being assessed.
In terms of informing on cyathostomin burden,
the GALA tests performed well when used to dis-
criminate horses at an encysted larval burden thresh-
old of 5000 worms (Table 4). At higher TMB
thresholds (10 000 +), the ROC AUC values were
lower (i.e. <0·7) indicating that the tests could not
discriminate well horses above and below thresholds
>10 000 larvae. When the ROC curve analysis was
repeated with horses segregated on the basis of
threshold of TWB (i.e. mucosal and luminal nema-
tode burdens, Table 4), the AUC values obtained
were higher at the 5000 TWB threshold compared
with when the horses were grouped according to
TMB. Again, with this in mind, the test results will
need to be interpretated in the context of the clinical
or treatment history and also with respect to the time
of year that the sample is anlysed. In northern tem-
perate climates, experimental studies (Reinemeyer
et al. 1986) have shown a peak of cyathostomin
larval luminal stages in spring (presumably derived
from emerged encysted larvae acquired during the
previous season). These larvae develop to adults in
late spring, which persist through summer and are
added to by immature worms, which co-contribute
to a second adult worm peak in late summer. In the
Reinemeyer et al. (1986) studies, there was a loss of
luminal stages in autumn; hence, the GALA
ELISA is likely to provide most diagnostic value if
used in these regions in autumn and winter when it
can be used to inform on the need for larvicidal treat-
ment, as well as in the diﬀerenential diagnosis of the
disease in horses presenting with weight loss and/or
diarrhoea. A cocktail of the ﬁve proteins, and combi-
nations thereof, will now be assessed to examine
which should be combined to optimise the test. A
balance will need to be struck between the resource
required to generate each protein and the diagnostic
value provided by the various combinations.
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